US PostUS Post
  • USA
  • WORLD
  • SPORTS
    • FOOTBALL
    • BASKETBALL
    • FORMULA 1
    • TENNIS
  • HEALTH
  • ENTERTAINMENT
  • LIFESTYLE
  • SCIENCE
  • TECHNOLOGY
What's Hot

A special gift from the Duke of Edinburgh to his youngest granddaughter

Taylor Swift

Miguel Bosé defends his opposition epidemiological theory

Facebook Twitter Instagram
US Post US Post
  • USA
  • WORLD
  • SPORTS
    • FOOTBALL
    • BASKETBALL
    • FORMULA 1
    • TENNIS
  • HEALTH
  • ENTERTAINMENT
  • LIFESTYLE
  • SCIENCE
  • TECHNOLOGY
Subscribe
US PostUS Post
Home»HEALTH»AstraZeneca’s concerns have nothing to do with safety: WHO
HEALTH

AstraZeneca’s concerns have nothing to do with safety: WHO

Alyssa BurkittBy Alyssa BurkittApril 3, 2021No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp
AstraZeneca’s concerns have nothing to do with safety: WHO
Share
Facebook Twitter Pinterest WhatsApp Reddit LinkedIn Email

The organization stated that it hopes to conduct scientific reviews of clinical trials in the United States, Chile and Peru.

According to CNN, the World Health Organization (WHO) told CNN in a statement on Tuesday that concerns about AstraZeneca’s Covid-19 vaccine efficacy data appear to have nothing to do with safety.

AstraZeneca announced on Monday that US trial data on the Covid-19 vaccine showed 79% efficacy against symptomatic diseases and 100% efficacy against serious diseases and hospitalizations. This is a press release, not official data used by the US Food and Drug Administration to determine whether to grant emergency use authorization for the vaccine.

The National Institute of Allergy and Infectious Diseases (NIAID) in a statement released on Tuesday highlighted the concerns raised by the trial safety and data monitoring committee that AstraZeneca used outdated information from the trial.

The WHO said: “As far as we know, the concerns about NIAID seem to be related to efficacy data, not safety.” “WHO has not seen the data from the US AZ clinical trial, nor has it seen the issue of NIAID. Specific details.”

The WHO said that SKBio’s AstraZeneca Vaccine Advisory Group and Serum Institute of India are providing its emergency use list and recommendations.

The WHO added: “We look forward to scientific reviews of clinical trials in the United States, Chile and Peru.”

.

health
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp

Related Posts

Empty seats on the plane will reduce the risk of infection

April 19, 2021

They claim that Sputnik V has an effective rate of 97.6%

April 19, 2021

What should women know about the Covid vaccine

April 18, 2021

Extending the suspension of Johnson & Johnson’s vaccine by one week is a fatal mistake: wettable powder

April 18, 2021
Add A Comment

Leave A Reply Cancel Reply

NEWS UPDATES

A special gift from the Duke of Edinburgh to his youngest granddaughter

April 19, 2021

Taylor Swift

April 19, 2021

Miguel Bosé defends his opposition epidemiological theory

April 19, 2021

Subscribe to Updates

Get the latest sports news from SportsSite about soccer, football and tennis.

Advertisement
US Post
Facebook Twitter Instagram Pinterest RSS
© 2021 Copyright USPOST.

Type above and press Enter to search. Press Esc to cancel.